Europe

• CVD is the leading cause of death and disability in the WHO European Region, responsible for about 42–45% of all deaths—equivalent to roughly 10,000 deaths per day (PMC, Weltgesundheitsorganisation).
• In ESC member countries, CVD accounts for over 3 million deaths annually, and consumes around 11% of healthcare spending (Oxford Academic).
• Age-standardized mortality has declined sharply (>50%) in high-income countries, but much less so in middle-income ones (PubMed).

United States

• CVD remains the #1 cause of death, with 941,652 deaths in 2022 alone—more than all cancer and accident deaths combined (The Washington Post).
• Between 2017 and 2020, around 48.6% of U.S. adults had some form of cardiovascular disease (The Washington Post).
• Projections suggest that by 2050, 61% of U.S. adults will develop CVD (People.com).

 India

• CVD causes approximately 26–27% of all deaths in India (The Lancet).
• Around 54 million Indians are living with CVD, a prevalence that has risen due to population growth and aging (PubMed).
• Among older adults (60+), the prevalence is around 33.6% (Wiley Online Library).
• Age-standardized CVD rates remain stable or rising in India—unlike the declining trend in the U.S. (PubMed).

 Comparative Overview

 Interpretation & Insights

• Europe has seen significant improvements, especially in wealthier nations, but CVD remains the dominant health burden.
• In the U.S., nearly half of adults live with CVD, and projections indicate alarming increases in the coming decades.
• India faces a dual challenge: a large and growing absolute number of cases due to demographics, with less progress in reducing age-adjusted mortality.

 Europe (EU)

• In the EU, total costs (including direct medical care, long-term care, productivity loss, and informal care) amount to approximately €282 billion per year, accounting for about 11% of total healthcare expenditure (pmc.ncbi.nlm.nih.gov).
• On average, this equals about €630 per person annually, with a range from ~€381 in Cyprus to ~€903 in Germany.

Summary:

• Total cost in the EU: approx. €282 billion/year
• Per capita: ~€630/year

 United States

• Hospitalizations related to cardiovascular diseases accounted for approximately $108 billion in 2021.
• Studies estimate that the average direct medical costs per adult CVD patient are about $18,953 per year (pmc.ncbi.nlm.nih.gov).
• According to MEPS data, total healthcare expenditures for heart disease among adults in the civilian noninstitutionalized population were $108.7 billion in 2017, with a median cost of $691 and a mean of $5,216 per patient (meps.ahrq.gov).

 Summary:

• Hospital-related costs: ~$108 billion/year
• Average annual direct cost per patient: ~$19,000

 India

• One clinical study found average direct treatment costs of approximately INR 247,822 (~ $3,842) per patient.
• Nationally, in 2010, the total economic burden of CVD in India was estimated at around $7.5 billion (sciencedirect.com).
• For major procedures such as heart surgery in the private sector, costs typically range from Rs 150,000 – 500,000 (~ $1,750–5,800), depending on type and complexity.

 Summary:

• Average per-patient cost: ~$3,842 (INR 247,822)
• National aggregate (2010): ~$7.5 billion

 Comparative Overview

 Interpretation

• Europe bears a massive health and economic burden from CVD, with hundreds of billions spent annually and high per capita costs.
• In the U.S., hospitalization alone accounts for over $100 billion per year, and average direct costs per patient are extremely high.
• India has significantly lower per-patient costs, but given the population size and rising prevalence, the national burden remains substantial—especially since many costs are paid out of pocket.